[Therapeutic guidelines for renal anemia in Japan].
Naito
Masayo
M
Fourth Department of Internal Medicine, Tokyo Women's Medical University.
Akiba
Takashi
T
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000008:administration & dosage; D015195:Drug Design; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006397:Hematinics; D006801:Humans; D007501:Iron / Q000008:administration & dosage; D007564:Japan; D007676:Kidney Failure, Chronic / Q000150:complications*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011788:Quality of Life; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000009:adverse effects*
D000806:Angiotensin-Converting Enzyme Inhibitors; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron; D001205:Ascorbic Acid